Back

Tamponade during immune checkpoint inhibitors therapy in lung cancer: case-reports and systematic review of the literature

1 September 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Cardio-oncology Cardio-Oncology ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Hazrije Mustafic

Pitie Salpetriere APHP University Hospital, Paris (France)

5 More presentations in this session

Presentation thumbnail
Echocardiography for the 10-year prediction of cardiomyopathy in long-term survivors of childhood cancer
Mr J. Leerink (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity
Doctor L. Michel (Essen, DE)
Abstract Slides
Presentation thumbnail
Cardioprotective effects of PCSK9 inhibitor evolocumab against doxorubicin-trastuzumab sequential treatments and ipilimumab-induced cardiotoxicity: the role of MyD88/NF-KB/mTORC1 pathways
Doctor V. Quagliariello (Naples, IT)
Abstract Slides
Presentation thumbnail
SGLT2 inhibitor dapagliflozin against anthracycline and trastuzumab-induced cardiotoxicity: the role of MYD88, NLRP3, Leukotrienes/Interleukin 6 axis and mTORC1 /Fox01/3a mediated apoptosis
Doctor V. Quagliariello (Naples, IT)
Abstract Slides
Presentation thumbnail
Cardiovascular risk factors during cancer treatment: prevalence, incidence and prognostic relevance.
Mr J. Caro Codon (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Cardio-oncology

The Event

Event poster

ESC Congress 2020

1 September 2020 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The cardiotoxic potencial of immune checkpoint inhibitors: insights from a Cardio-Oncology clinic
21 June 2025
thumbnail
Congress Presentation
Cardiac tamponade in a multiracial population- epidemiology, clinical characteristics and survival outcomes - a single centre experience
1 December 2022
thumbnail
Congress Presentation
Pericardial tamponade: the beginning or the end?
18 March 2022
thumbnail
Congress Presentation
Association between beta-1-blockers and reduced efficacy of pembrolizumab in non-small cell lung cancer
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources